Vaccine elicitation of HIV broadly neutralizing antibodies from engineered B cells
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-1723
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Vaccine elicitation of HIV broadly neutralizing antibodies from engineered B cells ; volume:11 ; number:1 ; day:17 ; month:11 ; year:2020 ; pages:1-10 ; date:12.2020
Nature Communications ; 11, Heft 1 (17.11.2020), 1-10, 12.2020
- Urheber
-
Huang, Deli
Tran, Jenny Tuyet
Olson, Alex
Vollbrecht, Thomas
Tenuta, Mary
Guryleva, Mariia V.
Fuller, Roberta P.
Schiffner, Torben
Abadejos, Justin R.
Couvrette, Lauren
Blane, Tanya R.
Saye, Karen
Li, Wenjuan
Landais, Elise
Gonzalez-Martin, Alicia
Schief, William
Murrell, Ben
Burton, Dennis R.
Nemazee, David
Voss, James E.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-020-19650-8
- URN
-
urn:nbn:de:101:1-2021011608320991125759
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:30 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Huang, Deli
- Tran, Jenny Tuyet
- Olson, Alex
- Vollbrecht, Thomas
- Tenuta, Mary
- Guryleva, Mariia V.
- Fuller, Roberta P.
- Schiffner, Torben
- Abadejos, Justin R.
- Couvrette, Lauren
- Blane, Tanya R.
- Saye, Karen
- Li, Wenjuan
- Landais, Elise
- Gonzalez-Martin, Alicia
- Schief, William
- Murrell, Ben
- Burton, Dennis R.
- Nemazee, David
- Voss, James E.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Author Correction: Vaccine elicitation of HIV broadly neutralizing antibodies from engineered B cells
Broadly Neutralizing Antibodies for HIV Eradication
The expanding array of HIV broadly neutralizing antibodies
Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies
Design clues from functional constraints and broadly neutralizing antibodies
Identification and characterization of broadly neutralizing antibodies targeting viral infections
Ultrapotent Broadly Neutralizing Human‐llama Bispecific Antibodies against HIV‐1
Broadly neutralizing antibodies and vaccine design against HIV-1 infection
HIV-1 cell-to-cell transmission and broadly neutralizing antibodies
Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
Pharmacokinetics and Immunogenicity of Broadly Neutralizing HIV Monoclonal Antibodies in Macaques
Broadly Neutralizing Antibodies as Treatment: Effects on Virus and Immune System
Author Correction: Vaccine elicitation of HIV broadly neutralizing antibodies from engineered B cells
Broadly Neutralizing Antibodies for HIV Eradication
The expanding array of HIV broadly neutralizing antibodies
Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies
Design clues from functional constraints and broadly neutralizing antibodies
Identification and characterization of broadly neutralizing antibodies targeting viral infections
Ultrapotent Broadly Neutralizing Human‐llama Bispecific Antibodies against HIV‐1
Broadly neutralizing antibodies and vaccine design against HIV-1 infection
HIV-1 cell-to-cell transmission and broadly neutralizing antibodies
Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
Pharmacokinetics and Immunogenicity of Broadly Neutralizing HIV Monoclonal Antibodies in Macaques
Broadly Neutralizing Antibodies as Treatment: Effects on Virus and Immune System
Author Correction: Vaccine elicitation of HIV broadly neutralizing antibodies from engineered B cells
Broadly Neutralizing Antibodies for HIV Eradication
The expanding array of HIV broadly neutralizing antibodies
Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies
Design clues from functional constraints and broadly neutralizing antibodies
Identification and characterization of broadly neutralizing antibodies targeting viral infections
Ultrapotent Broadly Neutralizing Human‐llama Bispecific Antibodies against HIV‐1
Broadly neutralizing antibodies and vaccine design against HIV-1 infection
HIV-1 cell-to-cell transmission and broadly neutralizing antibodies
Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
Pharmacokinetics and Immunogenicity of Broadly Neutralizing HIV Monoclonal Antibodies in Macaques